ClinicalTrials.gov
public full text
Public Domain
Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA)
The goal of this project is to improve the diagnostic pathway for patients with primary aldosteronism, by validating non-invasive biomarkers coupled with routine computed tomography imaging. The aim is to reduce reliance on invasive procedures, shorten diagnostic timelines, and enhance accessibility to definitive diagnosis and treatment globally.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large Multiethnic International Study#647639
- 68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism#852803
- Standardized Diagnosis and Treatment of Endocrine Hypertension#837261
- Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma#902235
- BESPOKE Study of ctDNA Guided Immunotherapy#808104
Record · ID 844050
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive